Care of the Treatment-naive Patient With HCV/HIV Coinfection

Slides:



Advertisements
Similar presentations
Hepatitis web study Hepatitis web study Sofosbuvir in HCV Genotype 2, 3 (PEG not an Option) POSITRON Phase 3 *Note: Published in tandem with FUSION Trial.
Advertisements

Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin + Peginterferon in Genotypes 1-3 PROTON Phase 2 Treatment Naïve Lawitz E, et al. Lancet.
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV-HIV Coinfection: HCV GT 1,2,3,4 PHOTON-2 Trial Phase 3 Molina JM, et al. IAC. 2014;
Hepatitis web study Hepatitis web study Sofosbuvir in Genotypes 2 or 3 VALENCE Trial Phase 3 Treatment Naïve and Treatment Experienced Zeuzem S, et al.
Hepatitis web study Hepatitis web study Sofosbuvir + Peginterferon + Ribavirin in Genotypes 1,4,5,6 ATOMIC Phase 2 Treatment Naïve Kowdley K, et al. Lancet.
Hepatitis web study Hepatitis web study Ledipasvir-Sofosbuvir in GT-1 and HIV Coinfection NIAID ERADICATE Trial Phase 2a Treatment Naïve and Treatment.
Hepatitis web study Hepatitis web study Daclatasvir + Sofosbuvir +/- Ribavirin in Genotypes 1-3 A Trial Phase 2a Treatment Naïve and Treatment.
Phase 3 Treatment Naïve and Treatment Experienced Renal Disease
Hepatitis web study Hepatitis web study Sofosbuvir in HCV-HIV Coinfection & HCV GT 1,2,3 PHOTON-1 Trial Phase 3 Sulkowski MS, et al. JAMA. 2014;312:
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV Recurrence Following Liver Transplantation Phase 2 Charlton M, et al. Gastroenterology.
Hepatitis web study Hepatitis web study Simeprevir in HIV Coinfection, GT-1 C212 Trial Phase 3 Treatment Naïve and Treatment Experienced Dieterich D, et.
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV GT 4 Egyptian Ancestry Trial Phase 2 Ruane PJ, et al. J Hepatol. 2015;62:
Abstract Results Objectives Results Conclusions Background Methods V-1637 Background-At the CORE center in Chicago, despite an on-site hepatitis clinic.
Hepatitis web study Hepatitis web study Telaprevir BID versus q8 in Treatment Naïve GT-1 OPTIMIZE (Study C211) Phase 3 Treatment Naïve Buti M, et al. Gastroenterology.
Hepatitis web study Hepatitis web study Sofosbuvir ELECTRON (Overview): 6 parts, 22 arms Phase 2 Treatment Naïve and Treatment Experienced Source: Gilead.
Hepatitis web study Hepatitis web study Sofosbuvir + Ribavirin in HCV Genotype 1 NIAID/NIH Trial Phase 2, Treatment Naïve Treatment Naïve (unfavorable.
Hepatitis web study Hepatitis web study Boceprevir with PEG + RBV in Genotype 1 SPRINT-1 Phase 2 Treatment Naïve Kwo PY, et al. Lancet. 2010;376:
Hepatitis web study Hepatitis web study Ledipasvir-Sofosbuvir in HCV Genotype 4 NIAID SYNERGY (Genotype 4) Phase 2 Treatment Naïve and Treatment Experienced.
Hepatitis web study Hepatitis web study Sofosbuvir + Peginterferon+ Ribavirin in HCV-HIV GT 1-4 Phase 2 Rodriguez-Torres M, et al. J Acquir Immune Defic.
Phase 3 Treatment-Naïve and Treatment-Experienced
Where Are We on the Path to Elimination of Chronic Hepatitis C?
EASL Recommendations on Treatment of Hepatitis C 2015 Treatment recommendations for HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis.
Daclatasvir + Sofosbuvir +/- Ribavirin in Genotype 1-3 Trial
Phase 3 Treatment-Naïve and Treatment-Experienced
Volume 63, Issue 1, Pages (July 2015)
American Association For Study Of Liver Disease and Infectious Diseases Society of America ,Guide Lines For Treatment Of Chronic Hepatitis C. Presented.
Pipeline & HCV UK-CAB 31 January 2009.
Phase 3 Treatment-Naïve and Treatment-Experienced
Phase 3b Treatment-Naive
Phase 3 Treatment-Naïve and Treatment-Experienced
Glecaprevir-Pibrentasvir in Non-Cirrhotic Genotype 2 ENDURANCE-2
Sofosbuvir plus Peg-Interferon and Ribavirin in Treatment Experienced Patients with Hepatitis C Virus and HIV Co-Infection Mehri Nikbin, MD Infectious.
Phase 2 Treatment Naïve HIV Coinfection
Talking to Patients About HCV Treatment
A Review of the Critical Role of Imaging in Primary Liver Malignancy
HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.
Chronic Hepatitis C Virus Infection
Outline.
Starting Strong: Initial Evaluation of the Patient With HCV
More Than Meets the Eye: Identifying Who Is at Risk for NASH
Case 53-year-old Black Man
The Aging Liver in the Aging HIV and HCV Patients
HCV Care in Unique Patient Populations
The HCV Revolution: Are You and Your Practice Ready?
HIV Management: An Update on the Latest EACS Guidelines
More Than Treatment.
HCV Screening.
Simeprevir in HIV Coinfection, GT-1 C212 Trial
Decision-making in the eRA of Treating to Target
Evaluation of the Patient With HCV Infection
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Ombitasvir + Paritaprevir + Ritonavir +/- Ribavirin in HCV GT4 PEARL-I
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
Phase 3 Treatment-Naïve and Treatment-Experienced
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Phase 2 Treatment Naïve and Treatment Experienced
Ledipasvir-Sofosbuvir +/- Ribavirin for 8 or 12 weeks in HCV GT1 ION-3
Elbasvir/Grazoprevir plus Sofosbuvir ± Ribavirin in Treatment-naive and Treatment-experienced Patients with Hepatitis C Virus Genotype 3 Infection and.
Phase 3 Treatment Naïve and Treatment Experienced HIV Coinfection
Update From Seattle 2017.
Advances in the Treatment of HCV Genotype 3 and HIV/HCV Coinfection
Hepatitis C: After the Diagnosis
A Guideline-Based Approach to HCV Care
What Does the Future Hold and What Will It Mean for Patients?
Phase 3 Treatment-Naïve and Treatment-Experienced
Volume 63, Issue 1, Pages (July 2015)
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Phase 3 Treatment-Naïve and Treatment-Experienced
Glecaprevir-Pibrentasvir in Non-Cirrhotic Genotype 2 ENDURANCE-2
Presentation transcript:

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Case 47-Year-Old Man With Asymptomatic HIV Infection

Case (cont)

Initial Clinical Presentation

Laboratory Results

HepaScore® A Composite Biomarker Panel for Liver Fibrosis

Hepatic Steatosis in Patients With HIV/HCV Coinfection

Biopsy Features of Steatohepatitis

Biopsy Interpretation

Next Step Abdominal Ultrasound to Screen for HCC

Treatment Now or Later?

Treatment of HCV in HIV-infected Persons Was Low in the PEG-IFN/RBV Era

PHOTON-1 Sofosbuvir Plus Ribavirin for the Treatment of HIV/HCV Coinfection in Treatment-naive Patients

Phase 3 HCV Treatment Pipeline

Conclusion Treat Now

Abbreviations

References

References (cont)

References (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.